Hostname: page-component-745bb68f8f-s22k5 Total loading time: 0 Render date: 2025-02-11T11:04:54.233Z Has data issue: false hasContentIssue false
  • English
  • Français

REPORT FROM THE CATALAN AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT (CAHTA)

Published online by Cambridge University Press:  01 October 1999

Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Recently, the advent and extension of vancomycin-resistant enterococci (VRE) has raised the awareness of the professional community, given that this antimicrobial is used as first-choice therapy for multiresistant gram-positive bacteria. The objectives are:

Type
TECHNOLOGY ASSESSMENT REPORTS
Information
International Journal of Technology Assessment in Health Care , Volume 15 , Issue 4 , October 1999 , pp. 767 - 769
Copyright
© 1999 Cambridge University Press